These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10197490)
1. Long-term follow up of a randomized, controlled trial on prophylactic sclerotherapy of small oesophageal varices in liver cirrhosis. Strauss E; Ribeiro MF; Albano A; Honain NZ; Maffei RA; Caly WR J Gastroenterol Hepatol; 1999 Mar; 14(3):225-30. PubMed ID: 10197490 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices: a prospective, controlled trial compared with endoscopic injection sclerotherapy. Gotoh Y; Iwakiri R; Sakata Y; Koyama T; Noda T; Matsunaga C; Ogata SI; Ishibashi S; Sakata H; Tsunada S; Fujimoto K J Gastroenterol Hepatol; 1999 Mar; 14(3):241-4. PubMed ID: 10197493 [TBL] [Abstract][Full Text] [Related]
3. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices. Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669 [TBL] [Abstract][Full Text] [Related]
4. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis. Kokawa H; Shijo H; Kubara K; Nakaoka K; Toriya H; Shirai Z; Okazaki M Am J Gastroenterol; 1993 Aug; 88(8):1206-11. PubMed ID: 8393274 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic endoscopic sclerotherapy of esophageal varices in liver cirrhosis--long-term follow-up and final results of a multicenter prospective controlled randomized trial in Vienna. Pötzi R; Bauer P; Schöfl R; Reichel W; Kerstan E; Renner F; Gangl A Endoscopy; 1993 May; 25(4):287-9. PubMed ID: 8330548 [TBL] [Abstract][Full Text] [Related]
6. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. Sauerbruch T; Wotzka R; Köpcke W; Härlin M; Heldwein W; Bayerdörffer E; Sander R; Ansari H; Starz I; Paumgartner G N Engl J Med; 1988 Jul; 319(1):8-15. PubMed ID: 3288871 [TBL] [Abstract][Full Text] [Related]
8. [Prophylactic sclerosing of esophageal varices. Results of a prospective randomized 7-year longitudinal study]. Wördehoff D; Spech HJ Dtsch Med Wochenschr; 1987 Jun; 112(24):947-51. PubMed ID: 3496202 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of patient outcome following sclerotherapy for esophageal varices. Sumino M; Toyonaga A; Tanikawa K J Gastroenterol; 1996 Jun; 31(3):387-93. PubMed ID: 8726831 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Witzel L; Wolbergs E; Merki H Lancet; 1985 Apr; 1(8432):773-5. PubMed ID: 2858664 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. Pötzi R; Bauer P; Reichel W; Kerstan E; Renner F; Gangl A Gut; 1989 Jun; 30(6):873-9. PubMed ID: 2666282 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Piai G; Cipolletta L; Claar M; Marone G; Bianco MA; Forte G; Iodice G; Mattera D; Minieri M; Rocco P Hepatology; 1988; 8(6):1495-500. PubMed ID: 3056821 [TBL] [Abstract][Full Text] [Related]
13. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Krige JE; Bornman PC; Goldberg PA; Terblanche J Arch Surg; 2000 Nov; 135(11):1315-22. PubMed ID: 11074888 [TBL] [Abstract][Full Text] [Related]
14. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025 [TBL] [Abstract][Full Text] [Related]
15. A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction. Kahn D; Krige JE; Terblanche J; Bornman PC; Robson SC Ann Surg; 1994 Jan; 219(1):34-9. PubMed ID: 8297173 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patients without hepatocellular carcinoma: a comparison of longterm survival between prophylactic therapy and emergency therapy. Ogusu T; Iwakiri R; Sakata H; Matsunaga K; Shimoda R; Oda K; Watanabe K; Ootani H; Kikkawa A; Ootani A; Tsunada S; Fujimoto K J Gastroenterol; 2003; 38(4):361-4. PubMed ID: 12743776 [TBL] [Abstract][Full Text] [Related]
17. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal. Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718 [TBL] [Abstract][Full Text] [Related]
18. The long-term morbidity and mortality rate in a cohort of patients with liver cirrhosis and oesophageal varices. Nevens F; Broeckaert L; Rutgeerts P; Van Steenbergen W; Fevery J Hepatogastroenterology; 1995; 42(6):979-84. PubMed ID: 8847055 [TBL] [Abstract][Full Text] [Related]
19. Injection sclerotherapy for bleeding esophageal varices in cirrhotic patients with hepatocellular carcinoma. Ng WD; Chan YT; Ho KK; Kong CK Gastrointest Endosc; 1989; 35(1):69-70. PubMed ID: 2537777 [No Abstract] [Full Text] [Related]
20. Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. De Franchis R; Primignani M; Arcidiacono PG; Rizzi PM; Vitagliano P; Vazzoler MC; Arcidiacono R; Rossi A; Zambelli A; Cosentino F Gastroenterology; 1991 Oct; 101(4):1087-93. PubMed ID: 1889702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]